We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

“Rewriting the Textbook” for Precision Medicine

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
Industry Insight

Meet the Scientists Bringing Back the Extinct Tasmanian Tiger

The biotech/genetic engineering company Colossal – co-founded in 2021 by renowned geneticist Professor George Church and serial entrepreneur Ben Lamm – announced it has begun a de-extinction project of the thylacine – an Australian marsupial commonly referred to as the “Tasmanian tiger”. Technology Networks interviewed the team to learn more.
Industry Insight

Broadening the Adoption of Pharmacogenomic Testing

Technology Networks recently had the pleasure of speaking to Dr. Philip Empey, to learn more about the Pharmacogenomics Center for Excellence and how it is working to prove the clinical utility of predictive PGx testing.
Industry Insight

Exploring Flow Electroporation for Cell Engineering

Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.
Industry Insight

Combining Coding and Biology To Engineer Human Cells

To learn more about new technologies being developed for drug discovery and cell therapy, Technology Networks spoke to bit.bio's Dr. Farah Patell-Socha and Furqan Iqbal.

Industry Insight

What’s Hot in Synthetic Biology Right Now?

In this opinion piece, Eric Rhodes, CEO of ERS Genomics, shares his roundup of some of the most exciting innovations in synthetic biology right now.
Industry Insight

Using Machine Learning To Enhance Biomarkers for Cancer Immunotherapy

In this interview, we spoke to Rachel Marty Pyke PhD, manager of bioinformatics science at Personalis, to find out how machine learning can be used to detect genomic instability as a biomarker for cancer immunotherapy.
Industry Insight

Bridging the Gap Between In Vitro and Animal Models of Liver Disease

We spoke to Dr. Audrey Dubourg, product manager at CN Bio to find out more about how its organ-on-chip platform could bridge the gap between the current 2D models and animal models, providing human-relevant insights into diseases such as non-alcoholic steatohepatitis.
Industry Insight

Advancing Synthetic Biology With Automation

In this piece, Adam Clore explores how smart automation can help synthetic biology companies become more resilient.

Industry Insight

The Impact of Funding on Longevity Research

To find out more about how early-stage funding could improve longevity research, we had the pleasure of speaking to Garri Zmudze, executive director of the Longevity Science Foundation.
Advertisement